ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
24/03/2026
Voltar para busca
Dado oficial do USPTO
MESOBLAST
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
28
Atualização mais recente
25/03/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
5, 42
Data de depósito
12/07/2013
Data de registro
11/03/2014
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
20/12/2024
Última transação
25/03/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
16
Localização do titular
Melbourne, AU
Examinador
LOVELACE, JAMES B
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
Mesoblast Limited
Mesoblast Limited
Representantes
Monica Riva Talley Sterne, Kessler, Goldstein & Fox P.L.L.C.
Classificação técnica
Classes Nice
Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Pharmaceutical preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; veterinary preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; biotechnology preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; medical preparations for the preventionmanagementdiagnosis and treatment of connective tissue and musco-skeletal disorders and indications but not including preparations for embryonic stem cells; diagnostic preparations and reagents for medical purposes but not including preparations and reagents for embryonic stem cells; culture fluidscultures of micro-organisms for medical purposes but not including cultures for embryonic stem cells; human allograft tissue but not including embryonic stem cells; animal allograft tissue but not including embryonic stem cells; human tissue and animal tissue for transplantation or implantationmedical and surgical purposes but not including embryonic stem cells; human cells including stem cells for medical or clinical use but not embryonic stem cells; animal cells including stem cells for medical or clinical use but not embryonic stem cells; pharmaceutical preparations for the treatmentreconstruction and repair of tissue but not including preparations for embryonic stem cells
Classe 42
Scientificmedical researchclinical researchpharmaceutical research and developmentadvisory and consultancy services in the field of T-cell productionT-cell immunotherapycell culture devicestissue engineering for cellular applications for humans and animalsstem cell bankingtissue bankingdrug discoveryvaccine screeningcell culture methodscell expansion technology including stem cell expansion technologycellular therapies including stem cell therapies and cellular transplants; none of the aforementioned services relating to embryonic stem cells
Publicações
Histórico de despachos e eventos da marca no USPTO.
28 publicações encontradas
NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
20/12/2024
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
20/12/2024
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
20/12/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
20/12/2024
E89R
TEAS SECTION 8 & 9 RECEIVED
11/09/2024
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
11/03/2023
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
05/05/2020
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
05/05/2020
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
05/05/2020
E815
TEAS SECTION 8 & 15 RECEIVED
11/03/2020
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
11/03/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
25/05/2017
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
25/05/2017
R.PR
REGISTERED-PRINCIPAL REGISTER
11/03/2014
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24/12/2013
PUBO
PUBLISHED FOR OPPOSITION
24/12/2013
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/12/2013
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
19/11/2013
ALIE
ASSIGNED TO LIE
19/11/2013
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
29/10/2013
XAEC
EXAMINER'S AMENDMENT ENTERED
29/10/2013
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
29/10/2013
GNEA
EXAMINERS AMENDMENT E-MAILED
29/10/2013
CNEA
EXAMINERS AMENDMENT -WRITTEN
29/10/2013
DOCK
ASSIGNED TO EXAMINER
25/10/2013
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
19/07/2013
NWAP
NEW APPLICATION ENTERED
16/07/2013
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace MESOBLAST ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.